HOME ABOUT US PRINT PUBLICATIONS SUBSCRIPTIONS CONTACT US TELL FRIEND RSS
 
Welcome to FDAweb
Pay Per View
Search our 49,902 - story database FREE
 
Free Items
 Warning Letters
 FDA Notices
 FDA Calendar
 

 FDA Whistleblowers



    








 
 
<< Prev  15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 Next >>
 
TXT Info on DTC Promotion Sent to OMB [46 Words] [ Price : $8.95]
Federal Register Notice: FDA submits a proposed collection of information on experimental study of direct-to-consumer promotion directed at adolescents to the Office of Management and Budget.
07/21/2014
 
 
TXT Breakthrough Designation for Pancreatic Cancer Therapy [118 Words] [ Price : $8.95]
FDA grants a breakthrough designation to Aduro BioTech for its pancreatic cancer combination treatment that consists of its CRS-207 and GVAX pancreas immunotherapies.
07/21/2014
 
 
TXT Panels to Discuss Testosterone Replacement Therapy [100 Words] [ Price : $8.95]
Federal Register Notice: FDA’s Bone, Reproductive and Urologic Drugs and the Drug Safety and Risk Management Advisory Committees will meet 9/18 to discuss a testosterone replacement therapy in males.
07/21/2014
 
 
TXT OPDP Letter Cites Concordia Phone Promo Script [200 Words] [ Price : $8.95]
CDER’ Office of Prescription Drug Promotion sends Concordia Pharmaceuticals an untitled letter that cites a telephone script directed at physicians for Kapvay (clonidine hydrochloride) extended-release tablets.
07/18/2014
 
 
TXT FDA Part of Probe Into FedEx Illegal Drug Courier Service [226 Words] [ Price : $8.95]
FDA criminal investigators contribute to U.S. government charges against FedEx for allegedly conspiring with two online pharmacy organizations to distribute controlled substances and prescription drugs to U.S. consumers without required prescriptions.
07/18/2014
 
 
TXT House Reps Want Info from FDA on Generic Labeling Proposal [396 Words] [ Price : $8.95]
House Oversight and Government Reform Committee chairman Darrell Issa (R-CA) and other representatives ask FDA for more information on its proposed rule to allow generic drug makers to make labeling changes when new safety information arises.
07/18/2014
 
 
TXT CA Court Allows Celgene Whistleblower Case to Proceed [287 Words] [ Price : $8.95]
A California federal court rules that a whistleblower and former Celgene sales representative can proceed with her False Claims Act lawsuit against the company.
07/18/2014
 
 
TXT FDA Moving Ahead with DTC Study of Adolescent Perceptions [323 Words] [ Price : $8.95]
FDA says it is moving forward with a proposed “Experimental Study of Direct-to-Consumer Promotion Directed at Adolescents.”
07/18/2014
 
 
TXT Healthcare Provider Concern on FDA Labeling Proposal: GPhA [273 Words] [ Price : $8.95]
The Generic Pharmaceutical Association submits a survey to FDA that reveals healthcare providers have serious concerns about the agency’s proposed rule on generic drug labeling.
07/18/2014
 
 
TXT Janssen Biotech to Begin Study in Multiple Myeloma [109 Words] [ Price : $8.95]
Janssen Biotech plans a new Phase 3 study in the fourth quarter of this year of daratumumab in mulitple myeloma patients ineligible for stem cell transplantation.
07/18/2014
 
 
<< Prev  15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34  Next >>
 

FERDIC INCORPORATED - P.O. Box 28, Camp Hill, PA 17001 | Phone: (717)731-1426 fax:(717)731-1427 Email: info@fdaweb.com